ZIM
PRTA icon

Zacks Investment Management’s Prothena Corp PRTA Stock Holding History

Zacks Investment Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,212
Closed -$275K – 706
2015
Q1 		$275K Buy
+7,212
New +$185K 0.01% 522
2014
Q4 		– Sell
-13,609
Closed -$302K – 726
2014
Q3 		$302K Buy
+13,609
New +$289K 0.01% 511

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Zacks Investment Management's PRTA Position: Q2 2015 in Review

Zacks Investment Management sold out of Prothena Corp (PRTA) in Q2 2015, closing a stake of 7,212 shares — an estimated $275K sold.

Zacks Investment Management first reported a position in PRTA in Q3 2014 and held it in 2 quarters. The position peaked at $302K in Q3 2014. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2015.

  • Zacks Investment Management reported no remaining Prothena Corp position as of Q2 2015 after selling out during the quarter.
  • Zacks Investment Management sold 7,212 Prothena Corp shares in Q2 2015, an estimated $275K.
  • Zacks Investment Management first reported a position in Prothena Corp in Q3 2014 and held it in 2 quarters.
  • Zacks Investment Management's Prothena Corp position peaked at $302K in Q3 2014.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2015.

Based on Zacks Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.